Large-scale growth of the Plasmodium falciparum malaria parasite in a wave bioreactor

[Display omitted] ► Breakthrough method for the scale-up of synchronous and asynchronous malaria blood stage cultures in wave bioreactor. ► Significant savings on both labour and material costs, and reduced likelihood of culture contamination. ► Method allows large scale isolation of various stages...

Full description

Saved in:
Bibliographic Details
Published inInternational journal for parasitology Vol. 42; no. 3; pp. 215 - 220
Main Authors Dalton, John P., Demanga, Corine G., Reiling, Sarah J., Wunderlich, Juliane, Eng, Jenny W.L., Rohrbach, Petra
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.03.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] ► Breakthrough method for the scale-up of synchronous and asynchronous malaria blood stage cultures in wave bioreactor. ► Significant savings on both labour and material costs, and reduced likelihood of culture contamination. ► Method allows large scale isolation of various stages of intra-erythrocytic stages from single culture. ► Methods will allow high throughput screening of compound libraries using identical live parasites. ► Methods will allow development of live or dead cell vaccines under GMP compliant standards. We describe methods for the large-scale in vitro culturing of synchronous and asynchronous blood-stage Plasmodium falciparum parasites in sterile disposable plastic bioreactors controlled by wave-induced motion (wave bioreactor). These cultures perform better than static flask cultures in terms of preserving parasite cell cycle synchronicity and reducing the number of multiple-infected erythrocytes. The straight-forward methods described here will facilitate the large scale production of malaria parasites for antigen and organelle isolation and characterisation, for the high throughput screening of compound libraries with whole cells or extracts, and the development of live- or whole-cell malaria vaccines under good manufacturing practice compliant standards.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0020-7519
1879-0135
DOI:10.1016/j.ijpara.2012.01.001